NMRA
Neumora Therapeutics Inc.
$3.02
+$0.09(+3.07%)
75
Overall
60
Value
91
Tech
--
Quality
Market Cap
$419.44M
Volume
4.58M
52W Range
$0.61 - $14.09
Target Price
$7.00
Key Metrics Overview
| Market Cap | $419.44M | P/E Ratio | N/A |
| 52W High | $14.09 | 52W Low | $0.61 |
| Div Yield | N/A | Payout Ratio | N/A |
| EPS Growth 3Y | N/A | 52W Position | 17.9% |
| Overall Score | 75 | Value Score | 60 |
| Quality Score | -- | Technical Score | 91 |
Growth Analysis
| EPS Current Est | $-1.43 | EPS Next Est | $-1.08 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
No data available
EBITDA (5Y)
No data available
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NMRA | $3.02 | +3.1% | 4.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Neumora Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW